HIGH POTENT PRODUCTS CATALOG
Bortezomib
Bortezomib
CAS Number: Synthetic chemistry
Description
Bortezomib is a dipeptide Boronic acid derivative and proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma.
API Type | ICH |
Quality | Oncology |
Therapeutic Category | Oncology |
Monograph Status | NA |
Granules Product Status | Commercial Available |
Regulatory Filing/Technical Package | US DMF |
Innovator Brands | Velcade |
Available dosage Form/Strength | Powder;Intravenous(3.5mg/ vial) |
Cabozantinib S Malate
Capecitabine
Capecitabine
CAS Number: 154361-50-9
Description
Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU).
API Type | Synthetic chemistry |
Quality | ICH |
Therapeutic Category | Oncology |
Monograph Status | A |
Granules Product Status | Commercial Available |
Regulatory Filing/Technical Package | CEP |
Innovator Brands | Xeloda |
Available dosage Form/Strength | Tablet (150/500 mg) |
Dasatinib
Dasatinib
CAS Number: 302962-49-8
Description
Dasatinib is a selective tyrosine kinase receptor inhibitor.
API Type | Synthetic chemistry |
Quality | ICH |
Therapeutic Category | Oncology |
Monograph Status | NA |
Granules Product Status | Commercial Available |
Regulatory Filing/Technical Package | US DMF |
Innovator Brands | Sprycel |
Available dosage Form/Strength | Tablet (20/50/70/80/100/140mg) |
Imatinib mesylate
Lapatinib Ditosylate
Lenvatinib Mesylate
Melphalan Hcl
Nilotinib Hydrochloride Monohydrate
Palbociclib
Ruxolitinib Phosphate
Sorafenib Tosylate
Pazopanib